 |
Levagen®, also known as Palmitoylethanolamide (PEA), is an endogenous fatty acid amide that has demonstrated a significant impact against various mechanisms that regulate the body’s inflammatory response, which in turn has impacts on bodily discomfort and immune health. Inflammation is the first biological response to external aggression: injury, toxic, chemical, or biological. The body’s inflammatory response is regulated by the balance between pro-inflammatory and anti-inflammatory mediators. One mechanism by which PEA may regulate the inflammatory response is by reducing mast cell degranulation and migration. While the potential benefits of standard PEA are limited by its absorption and bioavailability, a new form utilizing LipiSperse® technology is now available as Levagen®+, providing up to 1.8 times more bioavailability while also expanding the dosage forms that the ingredient can be formulated into. |
